Guselkumab trials for Psoriasis

All Guselkumab trials · All Psoriasis trials

Phase breakdown

Recruiting trials studying Guselkumab for Psoriasis

• A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
  NCT06663332 · Phase: Phase 3 · Ages: 3 Years and older · Sex: All (male and female) · 147 locations
• A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
  NCT07141004 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
  NCT07654751 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 3 locations
• A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
  NCT07532486 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
  NCT06586281 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
  NCT05669833 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 14 locations
• Immune Spatial Features of Guselkumab Cutaneous Response
  NCT05858632 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
  NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Multi-Center PAMPA Study
  NCT05004727 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
  NCT06974474 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
  NCT02103361 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 2 locations

Common questions

How many trials study Guselkumab for Psoriasis?

11 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.